Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8769943rdf:typepubmed:Citationlld:pubmed
pubmed-article:8769943lifeskim:mentionsumls-concept:C0001511lld:lifeskim
pubmed-article:8769943lifeskim:mentionsumls-concept:C0002823lld:lifeskim
pubmed-article:8769943lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:8769943lifeskim:mentionsumls-concept:C0063083lld:lifeskim
pubmed-article:8769943lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:8769943pubmed:issue1lld:pubmed
pubmed-article:8769943pubmed:dateCreated1996-12-30lld:pubmed
pubmed-article:8769943pubmed:abstractTextThe objective of this investigation was to evaluate the effect of ancrod, a fibrinogenolytic protease from Malayan pit viper venom, locally delivered through a photopolymerized biodegradable hydrogel in preventing postoperative adhesions. The experimental model involved ischemic and serosal injury to the uterine horns of rats with measurement of adhesions 7 days after injury. Ancrod was delivered intravenously for 5 days preoperatively through 3 days postoperatively, intraperitoneally for 5 days preoperatively, intraperitoneally for 3 days postoperatively, and locally via the hydrogel formed upon the uterine horns by photopolymerization of an aqueous precursor solution. Systemic defibrinogenation by intravenous administration pre-through postoperatively reduced the extent of adhesions by 63% without dose sensitivity from 5 to 20 units/kg/day. Preoperative defibrinogenation by intraperitoneal administration reduced adhesion extent by up to 57%, while postoperative administration was more effective, reducing adhesions by up to 84% with a dose-dependent response from 5 to 20 units/kg/day. Administration of ancrod by local release from a tissue-adherent hydrogel was more effective than either the hydrogel alone or the same amount of ancrod administered by postoperative intraperitoneal injection. Adhesions were reduced by 82% at a local dose of 10 units/kg, compared to a reduction of 68% due to the barrier properties of the gel alone (P < 0.01) and of 19% due to the same amount of drug given at the time of surgery (P < 0.001). Local delivery of ancrod from a tissue-adherent hydrogel barrier thus provided an efficacious prevention to postoperative adhesions while permitting administration of a low total dose of the protease.lld:pubmed
pubmed-article:8769943pubmed:languageenglld:pubmed
pubmed-article:8769943pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8769943pubmed:citationSubsetIMlld:pubmed
pubmed-article:8769943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8769943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8769943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8769943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8769943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8769943pubmed:statusMEDLINElld:pubmed
pubmed-article:8769943pubmed:monthFeblld:pubmed
pubmed-article:8769943pubmed:issn0022-4804lld:pubmed
pubmed-article:8769943pubmed:authorpubmed-author:HubbellJ AJAlld:pubmed
pubmed-article:8769943pubmed:authorpubmed-author:ChowdhuryS...lld:pubmed
pubmed-article:8769943pubmed:issnTypePrintlld:pubmed
pubmed-article:8769943pubmed:day15lld:pubmed
pubmed-article:8769943pubmed:volume61lld:pubmed
pubmed-article:8769943pubmed:ownerNLMlld:pubmed
pubmed-article:8769943pubmed:authorsCompleteYlld:pubmed
pubmed-article:8769943pubmed:pagination58-64lld:pubmed
pubmed-article:8769943pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:meshHeadingpubmed-meshheading:8769943-...lld:pubmed
pubmed-article:8769943pubmed:year1996lld:pubmed
pubmed-article:8769943pubmed:articleTitleAdhesion prevention with ancrod released via a tissue-adherent hydrogel.lld:pubmed
pubmed-article:8769943pubmed:affiliationDepartment of Chemical Engineering, University of Texas, Austin 78712, USA.lld:pubmed
pubmed-article:8769943pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8769943pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8769943pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8769943lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8769943lld:pubmed